Yeliz Guler

Yeliz Guler

Auto-generated profile, based on publicly available information

Yeliz Guler

Department of Cardiology, Basaksehir Cam and Sakura City Hospital, Istanbul, Turkey

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 February 2023 in Biomarkers in Medicine
Verified
Journal Article
Closed access
AEAslan Erdoğan
Aslan Erdoğan
ÖGÖmer Genç
Ömer Genç
DIDuygu Inan
Duygu Inan
UYUfuk YILDIZ
Ufuk YILDIZ
İBİsmail Balaban
İsmail Balaban
AKAli Karagoz
Ali Karagoz
Aim: This work was designed to investigate the relationship between cardiac outcomes and Naples Prognostic Score (NPS) among heart failure (HF) patients. Materials & methods: This retrospective obs... Plain language summary Heart failure is a serious condition that affects millions of individuals around the world. This study was designed to investigate whether there is a relationship between Nap... Tweetable abstract This study reveals Naples Prognostic Score (NPS) as a strong predictor of mortality and rehospitalization in patients with advanced heart failure. NPS also outperforms other scor...

26 September 2023 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
AEAslan Erdoğan
Aslan Erdoğan
DİDuygu İnan
Duygu İnan
ÖGÖmer Genç
Ömer Genç
UYUfuk YILDIZ
Ufuk YILDIZ
ADAyşe İrem Demirtola
Ayşe İrem Demirtola
AKAli Karagoz
Ali Karagoz
This study aimed to explore the potential association between the triglyceride–glucose index (TyG) and the atherogenic index of plasma (AIP)—both considered surrogate markers for atherosclerosis—and major adverse cardiovascular events (MACEs) in patients diagnosed with chronic coronary syndrome (CCS). We conducted a retrospective analysis, encompassing 715 consecutive patients with intermediate CCS risk, who presented at the outpatient clinic between June 2020 and August 2022. MACEs included non-fatal myocardial infarction, hospitalization for heart failure, cerebrovascular events, non-cardiac mortality, and cardiac mortality. The primary outcome was the composite occurrence of MACEs during the follow-up period. For time-to-event analysis of the primary outcome, we employed Kaplan–Meier plots and Cox proportional hazard models. The median age of the overall study population was 55 years, with a median follow-up duration of 17 months. Multivariate Cox regression analysis identified age, hypertension, Coronary Artery Disease–Reporting and Data System score, and TyG index as independent predictors of the primary outcome. Notably, individuals with high TyG levels exhibited a significantly higher primary outcome rate compared to those with low TyG levels (18.7% vs. 3.8%, p < 0.001). Similarly, patients with elevated TyG values demonstrated statistically higher rates of cerebrovascular events, hospitalizations for heart failure, non-fatal myocardial infarctions, non-cardiac mortality, and cardiac mortality. These findings suggest that TyG may serve as a predictive marker for adverse cardiovascular outcomes in patients with CCS.

14 October 2024 in European Journal of Clinical Investigation
Verified
Journal Article
Closed access
ÖGÖmer Genç
Ömer Genç
AYAbdullah Yıldırım
Abdullah Yıldırım
AEAslan Erdoğan
Aslan Erdoğan
EIErsin Ibisoglu
Ersin Ibisoglu
YGYeliz Guler
Yeliz Guler
IKIbrahim H. Kurt
Ibrahim H. Kurt

28 May 2025 in Heart, Lung and Circulation
Verified
Journal Article
Closed access
YGYeliz Guler
Yeliz Guler
AYAbdullah Yildirim
Abdullah Yildirim
OUOnur K. Uysal
Onur K. Uysal
ÖGÖmer Genç
Ömer Genç
GCGazi Capar
Gazi Capar
CKCevat Kirma
Cevat Kirma

30 March 2025 in Biomarkers in Medicine
Verified
Journal Article
Closed access
AYAbdullah Yıldırım
Abdullah Yıldırım
ÖGÖmer Genç
Ömer Genç
MEMert Evlice
Mert Evlice
AEAslan Erdoğan
Aslan Erdoğan
EPEmre Pacaci
Emre Pacaci
IKIbrahim Halil Kurt
Ibrahim Halil Kurt
This retrospective, multi-center study evaluates the relationships between novel liver function scoring systems - Albumin-Bilirubin (ALBI) score, EZ-ALBI, PALBI, and MELD-XI - and outcomes in patients undergoing transcatheter aortic valve implantation (TAVI). Feature importance was assessed with SHAP-values via the XGBoost-algorithm. The ALBI score exhibited the strongest association with 30-day mortality after TAVI (AUC = 0.723, p < 0.001), outperforming other scores in this regard and consistently demonstrating predictive power across various subgroup populations. Higher 30-day mortality rates were observed in the higher tertiles of the ALBI score compared to the lower tertiles (log-rank p-value = 0.004). The ALBI-based nomogram (C-index = 0.81, 95% CI:0.73-0.86, p = 0 < 001) demonstrated superior predictive power for 30-day mortality post-TAVI compared to the STS (C-index = 0.71, 95% CI :0.64-0.77, p = 0 < 001). In addition, the nomogram showed a significant improvement in reclassification (69.3%, p < 0.001) and a stronger discrimination 15.2%, p < 0.001) compared to the STS. It integrates nine variables, first ALBI score (SHAP:1.165), including NYHA class (0.594), body mass index (0.510), glomerular filtration rate, creatinine, hemoglobin, gender, predilatation requirement, presence of chronic kidney disease, and providing a comprehensive risk assessment tool. This study exhibits the significance of liver dysfunction with AS patients and suggests incorporating liver function parameters in pre-operative risk assessments for better clinical outcomes in TAVI procedures.

3 March 2025 in Vascular Medicine
Verified
Journal Article
Closed access
YGYeliz Guler
Yeliz Guler
ÖGÖmer Genç
Ömer Genç
FAFurkan Akbas
Furkan Akbas
AYAbdullah Yıldırım
Abdullah Yıldırım
ICIlyas Cetin
Ilyas Cetin
CKCevat Kirma
Cevat Kirma
Introduction: Peripheral artery disease (PAD) is a common manifestation of atherosclerosis. Despite the effectiveness of endovascular therapy (EVT), patients with PAD often face poor prognoses. This study investigates the relationship between specific inflammatory indices and wound healing in patients with Fontaine stage 4 chronic limb-threatening ischemia (CLTI). Methods: From June 2021 to January 2024, 168 patients with Fontaine stage 4 CLTI, totaling 185 affected extremities, who underwent successful EVT, were assessed retrospectively. Patients were categorized based on wound healing post-EVT. The Naples prognostic score (NPS), pan-immune inflammation value (PIV), systemic immune-inflammation index (SII), and systemic inflammation response index (SIRI) were calculated. Discrimination and decision curve analyses were used to explore the link between inflammation and wound healing. Results: Wound healing was observed in 142 (76.8%) patients post-EVT. Nonhealing patients exhibited higher indices of NPS, PIV, SII, and SIRI. NPS (aOR = 0.381, 95% CI 0.215–0.675, p = 0.001), PIV (aOR = 0.997, 95% CI 0.996–0.999, p < 0.001), SII (aOR = 0.997, 95% CI 0.996–0.997, p < 0.001), and SIRI (aOR = 0.443, 95% CI 0.313–0.625, p < 0.001) were independently predictive of wound healing. SIRI (AUC = 0.840, 95% CI 0.777–0.904) demonstrated superior predictive ability compared to PIV (AUC = 0.799, 95% CI 0.722–0.876, p dif < 0.001), SII (AUC = 0.788, 95% CI 0.712–0.865, p dif < 0.001), and NPS (AUC = 0.760, 95% CI 0.681–0.838, p dif < 0.001). SIRI also showed higher net reclassification improvement over PIV (68.4%, p dif < 0.001), SII (38.5%, p dif = 0.024), and NPS (29.8%, p dif = 0.079). All inflammatory indices, especially SIRI, provided prognostic value in determining wound healing at high treatment thresholds (> 40%). Conclusion: In patients with CLTI undergoing EVT, SIRI, SII, PIV, and NPS may help predict the potential for wound healing during in-hospital follow up, with SIRI being the strongest predictor.